Nucleoside reverse transcriptase inhibitors (NRTIs)

L 6 Pill - gray capsule-shape

Pill with imprint L 6 is Gray, Capsule-shape and has been identified as Lamivudine 300 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Lamivudine is used in the treatment of Hepatitis B; HIV Infection; Occupational Exposure; Nonoccupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Lamivudine (Lamivudine [ la-miv-ue-deen ])-L 6-300 mg-Gray-Capsule-shape
Lamivudine (Lamivudine [ la-miv-ue-deen ])-L 6-300 mg-Gray-Capsule-shape
Lamivudine (Lamivudine [ la-miv-ue-deen ])-L 6-300 mg-Gray-Capsule-shape

Lamivudine
Generic Name: lamivudine [ la-miv-ue-deen ]
Imprint: L 6
Strength: 300 mg
Color: Gray
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 68180-0603
Inactive Ingredients: Microcrystalline cellulose, Crospovidone, Ferrosoferric oxide, Hypromelloses, Magnesium stearate, Polyethylene glycol, Povidone, Titanium dioxide,
Latest News
Related Drugs